Open insulin, 'DIY bio' and the future of pharma
Thursday, September 13, 2018 - 09:31
in Mathematics & Economics
The development, manufacture and sale of pharmaceutical drugs in the United States is a complex landscape involving intellectual property and strict federal regulations.